Recent developments in the management of severe asthma

Howraman Meteran*, Louise Lindhardt Tønnesen, Pradeesh Sivapalan, Truls Sylvan Ingebrigtsen, Jens Ulrik Stæhr Jensen

*Corresponding author af dette arbejde
2 Citationer (Scopus)

Abstract

Fevipiprant is unlikely to be implemented as a future treatment for severe asthma, while tezepelumab may be a future treatment option for patients with severe asthma with and without eosinophilic inflammation https://bit.ly/3KE1BH4.

OriginalsprogEngelsk
Artikelnummer210178
TidsskriftBreathe
Vol/bind18
Udgave nummer1
Sider (fra-til)210178
ISSN1810-6838
DOI
StatusUdgivet - mar. 2022

Fingeraftryk

Dyk ned i forskningsemnerne om 'Recent developments in the management of severe asthma'. Sammen danner de et unikt fingeraftryk.

Citationsformater